Factors regulating arteriogenesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 7, 2003, Pages 1143-1151

  Schaper, Wolfgang ^a   Scholz, Dimitri ^b  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b NONE

Author keywords

Arteriogenesis; Factors

Indexed keywords

COLONY STIMULATING FACTOR; CYTOKINE; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; NITRIC OXIDE; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ARTERIAL PRESSURE; ARTERIOLE; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTERY OCCLUSION; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; COLLATERAL CIRCULATION; GENETIC ASSOCIATION; HUMAN; HYPOXIA; INFLAMMATION; ISCHEMIA; LEUKOCYTE ADHERENCE; MAST CELL; MOLECULAR MECHANICS; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; STEM CELL;

ANIMALS; ANOXIA; ARTERIES; ARTERIOLES; ARTERIOSCLEROSIS; COLLATERAL CIRCULATION; ENDOTHELIUM, VASCULAR; GROWTH SUBSTANCES; HEMORHEOLOGY; HUMANS; ISCHEMIA; MONOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS; TERMINOLOGY; VASCULITIS;

EID: 0038785755     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000069625.11230.96     Document Type: Review

References (83)

1. Fulton WFM. Arterial anastomoses in the coronary circulation. In: Fulton WFM, ed. The Coronary Arteries: Arteriography, Microanatomy, and Pathogenesis of Obliterative Coronary Artery Disease. Springfield, Ill: Thomas; 1965:72-128.
2. Schaper W. The Collateral Circulation of the Heart. Amsterdam: Elsevier; 1971.
3. Schaper W, Scholz D. Growth and remodeling of coronary collateral vessels. In: LaFont A, Topol EJ, eds. Arterial Remodeling: a Critical Factor in Restenosis. Boston: Kluwer; 1997:31-48.
4. Hoefer IE, van Royen N, Rectenwald JE, Bray EJ, Abouhamze Z, Moldawer LL, Voskuil M, Piek JJ, Buschmann IR, Ozaki CK. Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis. Circulation. 2002;105:1639-1641.
5. Scholz D, Ziegelhoeffer T, Friedrich C. Molecular biology of collateral circulation. In: Lanzer P, Topol EJ, eds. Pan Vascular Medicine. Berlin: Springer; 2002.
6. Dvorak H, Brown L, Detmar M, Dvorak A. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029-1039.
7. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nature Med. 2000;6:389-395.
8. Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, Krieger JE, Manseau EJ, Harvey VS, Eckelhoefer IA, Feng D, Dvorak AM, Mulligan RC, Dvorak HF. Heterogeneity of the angiogenic response innduced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest. 2000;80:99-115.
9. Carmeliet P. Clotting factors build blood vessels. Science. 2001;293: 1602-1604.
10. Ito WD, Arras M, Scholz D, Winkler B, Htun P, Schaper W. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol. 1997;273:H1255-H1265.
11. Scholz D, Ito W, Fleming I, Deindl E, Sauer A, Babiak A, Bühler A, Wiesnet M, Busse R, Schaper J, Schaper W. Ultrastructure and molecular histology of rabbit hindlimb collateral artery growth. Virchows Arch. 2000;436:257-270.
12. Scholz D, Ziegelhoeffer T, Helisch A, Wagner S, Friedrich C, Podzuweit T, Schaper W. Contribution of arteriogenesis and angiogenesis to post-occlusive hindlimb perfusion in mice. J Mol Cell Cardiol. 2002;34:775-787.
13. Schaper W. Experimental infarcts and the microcirculation. In: Hearse DJ, Yellon DM, eds. Therapeutic Approaches to Myocardial Infarct Size Limitation. New York: Raven Press; 1984:79-90.
14. Görge G, Schmidt T, Ito BR, Pantely GA, Schaper W. Microvascular and collateral adaptation in swine hearts following progressive coronary artery stenosis. Basic Res Cardiol. 1989;84:524-535.
15. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet. 1996;348:370-374.
16. Isner J. Vascular endothelial growth factor: gene therapy and therapeutic angiogenesis. Am J Cardiol. 1998;82:63s-64s.
17. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner J. Mouse model of angiogenesis. Am J Pathol. 1998;152:1667-1679.
18. Isner JM. Myocardial gene therapy. Nature. 2002;415:234-239.
19. Schwarz ER, Kloner RA. Direkte Applikation der DNA für vascular endothelial growth factor (VEGF) in die Randbereiche infarzierten Myokards induziert Angiogenese ohne Verbesserung der regionalen Myokardperfusion bei Ratten. Z Kardiol. 1999;8(Suppl 1):675. Abstract.
20. Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angiomagenesis. Nature Med. 2000;6:1102-1103.
21. Schmidt RF, Thews G. Physiologie des Menschen. Berlin: Springer; 1997.
22. Busse R, Fleming I. Regulation and functional consequences of endothelial nitric oxide formation. Ann Med. 1995;27:331-340.
23. 2+ independent activation of the endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 1999;96:1123-1128.
24. Thoma R. Untersuchungen über die Histogenese und Histomechanik des Gefäßsystems. Stuttgart: F. Enke; 1893.
25. Murray CD. The physiological principle of minimum work applied to the angle of branching arteries. J Gen Physiol. 1926;9:835-841.
26. Hoffman JIE, Spaan JAE. Pressure-flow relations in coronary circulation. Physiol Rev. 1990;70:331-390.
27. Hacking WJG, VanBavel E, Spaan JAE. Shear stress is not sufficient to control growth of vascular networks: a model study. Am J Physiol. 1996;270:H364-H375.
28. Schaper W. Quo vadis collateral blood flow? A commentary on a highly cited paper. Cardiovasc Res. 2000;45:220-223.
29. Schaper W, Piek JJ, Munoz-Chapuli R, Wolf C, Ito W. Collateral circulation of the heart. In: Ware JA, Simons M, eds. Angiogenesis and Cardiovascular Disease. New York: Oxford University Press; 1999: 159-198.
30. Scholz D, Cai WJ, Schaper W. Arteriogenesis, a new concept of vascular adaptation in occlusive disease. Angiogenesis. 2001;4:247-257.
31. Price RJ, Less JR, Van Gieson EJ, Skalak TC. Hemodynamic stresses and structural remodeling of anastomosing arteriolar networks: design principles of collateral arterioles. Microcirculation. 2002;9:111-124.
32. Schaper W, Adili F, Balzer J, Pipp F, Schmitz-Rixen T. Venous shunting of collateral flow after femoral artery occlusion markedly increases fluid shear stress and collateral vessel growth in a chronic pig model. J Vasc Res. 2002;39:62. Abstract.
33. - channels. Gen Pharmacol. 1996;27:1131-1140.
34. Ziegelhoeffer T, Scholz D, Helish A, Wagner S, Schaper W. Swelling cell-doing well? Volume-regulated chloride channels and arteriogenesis. J Mol Cell Cardiol. 2002;34:A71. Abstract
35. Ali MH, Schumacker PT. Endothelial responses to mechanical stress: where is the mechanosensor? Crit Care Med. 2002;30:S198-S206.
36. Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev. 2001;81:1415-1459.
37. Gimbrone MA Jr, Resnick N, Nagel T, Khachigian LM, Collins T, Topper JN. Hemodynamics, endothelial gene expression, and atherogenesis. Ann N Y Acad Sci. 1997;801:1-10.
38. Khachigian LM, Anderson KR, Halnon NJ, Gimbrone MJ, Resnick N, Collins T. Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain promoter. Arterioscler Thromb Vasc Biol. 1997;17:2280-2286.
39. Vosschulte R. Kollateralwachstum. Einflüsse von Wachstumsfaktoren und Matrixmetalloproteinasen auf die Zellproliferation und Zellmigration. In: Max-Planck-Institut für Physiologische und Klinische Forschung. Abteilung Experimentelle Kardiologie. Giessen: Justus-Liebig Universität Giessen; 1999:88.
40. Geary RL, Kohler TR, Vergel S, Kirkman TR, Clowes AW. Time course of flow-induced smooth muscle cell proliferation and intimal thickening in endothelialized baboon vascular grafts. Circ Res. 1994;74:14-23.
41. Jackson ZS, Gotlieb AI, Langille BL. Wall tissue remodeling regulates longitudinal tension in arteries. Circ Res. 2002;90:918-925.
42. Hollenberg NK. Collateral arterial growth and reactivity: lessons from the limb and renal blood supply. In: Schaper W, Schaper J, eds. Collateral Circulation-Heart, Brain, Kidney, Limbs. Boston: Kluwer Academic Publishers; 1993:1-15.
43. Heil M, Ziegelhoeffer T, Helisch A, Wagner S, Martin S, Kuziel WA, Schaper W. Arteriogenesis (collateral artery growth) after femoral artery occlusion is reduced in mice lacking CC-chemokine-receptor-2. Circulation. 2002;106 (Suppl II):1390. Abstract.
44. Ito W, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res. 1997;80:829-837.
45. Breier G, Blum S, Peli J, Groot M, Wild C, Risau W, Reichmann E. Transforming growth factor-b1 and Ras regulate the VEGF/VEGF receptor system during tumor angiogenesis. Int J Cancer. 2002;97:142-148.
46. Carmeliet P, Moons L, Luttun A, Vincenti V, Compemolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate K, Foidart J-M, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert J-M, Collen D, Persico G. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nature Med. 2001;7:575-583.
47. Scholz D, Elsaesser H, Sauer A, Friedrich C, Luttun A, Carmeliet P, Schaper W. Bone marrow transplantation abolishes inhibition of arteriogenesis in placenta growth factor (PIGF) -/- mice. J Mol Cell Cardiol. 2003;35:177-184.
48. Pipp F, Heil M, Issbrücker K, Ziegelhöffer T, Martin S, van den Heuvel J, Weich H, Fernandez B, Clauss M, Schaper W. VEGFR-1-selective VEGF homologue P1GF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ Res. 2003;92:378-385.
49. Heil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M, Schaper W. Blood monocytes concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol. 2002;283:H2411-H2419.
50. Toda S, Tokuda Y, Koike N, Yonemitsu N, Watanabe K, Koike K, Fujitani N, Hiromatsu Y, Sugihara H. Growth factor-expressing mast cells accumulate at the thyroid tissue-regenerative site of subacute thyroiditis. Thyroid. 2000;10:381-386.
51. Wolf C, Cai W-J, Vosschulte R, Koltai S, Mousavipour D, Scholz D, Afsah-Hedjri A, Schaper W, Schaper J. Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J Mol Cell Cardiol. 1998;30:2291-2305.
52. Ziegelhoeffer T, Heil M, Voswinckel R, Fernandez B, Kostin S, Schaper W. Bone marrow derived stem cells do not differentiate into vascular cells during collateral artery growth in mice. Circulation. 2002;106 (Suppl 11):413. Abstract.
53. Ziegelhoeffer T, Hoefer IE, van Royen N, Buschmann IR. Effective reduction in collateral artery formation through matrix metalloproteinase inhibitors. Circulation. 1999;100 (Suppl 1):3719. Abstract.
54. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res. 1995;76:980-986.
55. Yang HT, Ren J, Laughlin MH, Terjung RL. Prior exercise training produces NO-dependent increases in collateral blood flow after acute arterial occlusion. Am J Physiol. 2002;282:H301-H310.
56. Ziche M, Morbidelli L. Nitric oxide and angiogenesis. J Neuro-Oncol. 2000;50:139-148.
57. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567-2578.
58. Abraham JA, Mergia A, Whang JL, Gospodarowicz D, Fiddes JC. Nucleotide sequence of a bong the angiogenic p fibroblast growth factor. Science. 1986;233:545-548.
59. Quinkler W, Maasberg M, Bernotat-Danielowski S, Luthe N, Sharma HS, Schaper W. Isolation of heparin-binding growth factors from bovine, porcine and canine hearts. Eur J Biochem. 1989;181:67-73.
60. Deindl E, Buschmann I, Hoefer I, Podzuweit T, Boengleg K, Vogel S, van Royen N, Fernandez B, Schaper W. Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Rec. 2001;89:779-786.
61. Arras M, Mollnau H, Strasser R, Wenz R, Ito WD, Schaper J, Schaper W. The delivery of angiogenic factors to the heart by microsphere therapy. Nature Biotechnol. 1998;16:159-162.
62. Fernandez B, Bueler A, Wolfram S, Kostin S, Espanion G, Franz WM, Nieman H, Doevedans PA, Schaper W, Zimmermann R. Transgenic myocardial overexpression of fibroblast growth factor-1 increases coronary artery density and branching. Circ Res. 2000;87:207-213.
63. Wolfram S, Ziegelhoeffer T, Fernandez B, Coffin JD, Wagoner S, Helish A, Schaper W. Arteriogenesis on demand in exercising mice expressing FGF-2 under the control of the phosphoglycerate kinase promoter. J Am Coll Cardiol. 2002;39:204A. Abstract.
64. Deindl E, Neubauer E, Fernandez B, Tomas S, Podzuweit T. Collateral artery growth in rabbit is not dependent on ischemia or an increased expression of VEGF. Circulation. 2000;102:11-51.
65. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol. 1994;267:H1263-H1271.
66. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;89:2183-2189.
67. Isner J, Walsh K, Symes J, Pieczek A, Takeshita S, Lowry J, Rosenfield K, Weir L, Brogi E, Jurayj D. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Human Gene Ther. 1996;7:959-988.
68. Henry TD, Annex BH, Azrin MA, McKendall GR, Willerson JT, Hendel RC, Giordano FJ, Klein R, Gibson CM, Berman DS, Luce CA, McCluskey ER. Double blind, placebo controlled trial of recombinant human vascular endothelial growth factor: the Viva Trial. J Am Coll Cardiol. 1999;33 A:384A.
69. Henry TD, Annex BH, Azrin MA, McKendall GR, Willerson JT, Hendel RC, Giordano F, Klein R, Gibson M, Berman DS, Luce CA, McCluskey ER. Final results of the VIVA trial of rhVEGF for human therapeutic angiogenesis. Circulation. 1999;100:1-476.
70. Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet P, Windecker S, Eberli F, Meier B. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation. 2001;104:1994-1995.
71. Buschmann I, Ito W, Höfer I, Weiß G, Kostin S, Schaper J, Schaper W. GM-CSF promotes collateral artery growth via prolongation of macrophage survival. In: J Mol Cell Cardiol. 1998;30 (Suppl):494. Abstract.
72. Böngler K, Deindl E, Neubauer E, Fernandez B, Pipp F, Schaper W. CARP is upregulated in growing collateral arteries. J Mol Cell Cardiol. 2001;33 (Suppl):A15. Abstract.
73. Van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogenesis: a new concept for the treatment of arterial occlusive disease. Cardiovasc Res. 2001;49:543-553.
74. Matsunada T, Warltier DC, Weihrauh DW, Monitz M, Tessmer J, Chilian WM. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor, and nitric oxide. Circulation. 2000;102:3098-3103.
75. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992;12:5447-5454.
76. Wang GL, Semenza GL. Characterization of hypoxia-inducible factor 1 and regulation of the DNA binding activity by hypoxia. J Biol Chem. 1993;268:21513-21518.
77. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 1994;269:23757-23763.
78. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor by hypoxia. J Biol Chem. 1995;270:13333-13340.
79. Kalka C, Masuda H, Takahashi T, Kalka-Moll W, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA. 2000;97:3422-3427.
80. Cai WJ, Vosschulte R, Koltai S, Kostin S, Schaper W, Schaper J. Extracellular proteolysis is involved in coronary collateral vessel development in dog. J Mol Cell Cardiol. 1997;29:A128.
81. Cai WJ, Vosschulte R, Afsah-Hedrij A, Koltai S, Koscic E, Scholz D, Kostin S, Schaper W, Schaper J. Altered balance between extracellular proteolysis and antiproteolysis is associated with adaptive coronary arteriogenesis. J Mol Cell Cardiol. 2000;32:997-1011.
82. Cai W-J, Koltai S, Kocsis E, Scholz D, Kostin S, Luo X, Schaper W, Schaper J. Remodeling of the adventitia during coronary arteriogenesis. Am J Physiol. 2003;284:H31-H40.
83. Cai W-J, Koltai S, Scholz D, Schaper W, Schaper J. Connexin 37 and desmin, early markers for arteriogenesis in canine heart. J Mol Cell Cardiol. 2001;33:A17.